Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Public ClinicalTrials.gov record NCT02522767. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 4 g Extended Release Granules (Sachet) for the Induction of Clinical and Endoscopic Remission in Active, Mild to Moderate Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this trial is to investigate the efficacy of mesalamine for the induction of clinical and endoscopic remission in subjects with active, mild to moderate UC. Subject will receive 4 g extended release granules (sachet) once daily.
Study identification
- NCT ID
- NCT02522767
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 228 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2015 (Actual)
- Primary completion
- Feb 6, 2018 (Actual)
- Completion
- Apr 3, 2018 (Actual)
- Last update posted
- Mar 15, 2021
2015 – 2018
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Preferred Research Partners | Little Rock | Arkansas | — | — |
| United Research Institute | Murrieta | California | — | — |
| Research Associates of South Florida, LLC | Miami | Florida | — | — |
| IMIC | Palmetto Bay | Florida | — | — |
| Medical Research Center of Florida | Pembroke Pines | Florida | — | — |
| Lenus Research and Medical Group | Sweetwater | Florida | — | — |
| Clinical Trials of SWLA, LLC | Lake Charles | Louisiana | — | — |
| Cumberland Research Associates, LLC | Fayetteville | North Carolina | — | — |
| Wilmington Gastroenterology Associates | Wilmington | North Carolina | — | — |
| Associates in Gastroenterology, PLC | Hermitage | Tennessee | 37076 | — |
| Quality Medical Research, PLLC | Nashville | Tennessee | — | — |
| BI Research Center | Houston | Texas | — | — |
| Biopharma Informatic Inc. | Houston | Texas | — | — |
| Digestive Health Center | Pasadena | Texas | — | — |
| DM Clinical Research | Tomball | Texas | — | — |
| Advanced Research Institute | Ogden | Utah | — | — |
| New River Valley Research Institute | Christiansburg | Virginia | — | — |
| Digestive & Liver Disease Specialists | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02522767, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02522767 live on ClinicalTrials.gov.